This trial is active not recruiting!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Metastatic Liver Carcinoma, Stage IV Liver Cancer, Stage IVA Liver Cancer or Stage IVB Liver Cancer
and you are
over 18
years old
1
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

This clinical trial studies the side effects and best way to perform yttrium Y-90 radioembolization in treating patients with liver cancer that has spread to other places in the body (metastatic). Yttrium Y-90 radioembolization is a therapy that injects radioactive microspheres directly into an artery that feeds liver tumors to cut off their blood supply. Performing yttrium Y-90 radioembolization in a single session may make treatment faster, minimize patient travel, and decrease the overall cost of the procedure.

Provided treatments

  • Procedure: Angiography
  • Procedure: Computed Tomography
  • Procedure: Planar Imaging
  • Radiation: Radioembolization
  • Procedure: Single Photon Emission Computed Tomography
  • Radiation: Technetium Tc-99m Albumin Aggregated
  • Other: Yttrium Y 90 Resin Microspheres

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03028311. The sponsor of the trial is M.D. Anderson Cancer Center and it is looking for 12 volunteers for the current phase.
Official trial title:
Feasibility of Single Session In-Room Yttrium-90 Radioembolization Diagnostic Angiography and Treatment